{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T17:13:28Z","timestamp":1792257208241,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejogrb.2023.09.023","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T12:11:52Z","timestamp":1695816712000},"page":"143-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Cell free DNA screening for fetal aneuploidy in Ireland: An observational study of outcomes following insufficient fetal fraction"],"prefix":"10.1016","volume":"290","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7407-4493","authenticated-orcid":false,"given":"L.","family":"Creswell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Doddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.F.","family":"Nazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.W.","family":"Lindow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"O'Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejogrb.2023.09.023_b0005","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/humrep\/deh117","article-title":"Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report","volume":"19","author":"Flori","year":"2004","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.09.023_b0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/pd.1700","article-title":"Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast","volume":"27","author":"Alberry","year":"2007","journal-title":"Prenat Diagn"},{"issue":"9","key":"10.1016\/j.ejogrb.2023.09.023_b0015","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a023085","article-title":"Noninvasive prenatal screening for genetic diseases using massively parallel sequencing of maternal plasma DNA","volume":"5","author":"Chitty","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.09.023_b0020","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/uog.17484","article-title":"Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis","volume":"50","author":"Gil","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.09.023_b0025","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/uog.20284","article-title":"Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis","volume":"53","author":"Gil","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.09.023_b0030","first-page":"636","article-title":"Non-invasive prenatal testing (NIPT) - We Need a National Programme","volume":"115","author":"Petch","year":"2022","journal-title":"Ir Med J"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.09.023_b0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/uog.23756","article-title":"Clinical experience with non-invasive prenatal screening for single-gene disorders","volume":"59","author":"Mohan","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.09.023_b0040","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/1471-0528.17386","article-title":"The accuracy of cell-free DNA screening for fetal segmental copy number variants: A systematic review and meta-analysis","volume":"130","author":"Raymond","year":"2023","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.09.023_b0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/uog.21945","article-title":"Genome-wide cfDNA testing of maternal blood","volume":"55","author":"Jani","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.09.023_b0050","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3390\/jcm3030809","article-title":"Chromosomal mosaicism in human feto-placental development: implications for prenatal diagnosis","volume":"3","author":"Grati","year":"2014","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.09.023_b0055","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/pd.5049","article-title":"Discordant non-invasive prenatal testing (NIPT) - a systematic review","volume":"37","author":"Hartwig","year":"2017","journal-title":"Prenat Diagn"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.09.023_b0060","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/pd.4126","article-title":"The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies","volume":"33","author":"Canick","year":"2013","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.09.023_b0065","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/uog.12331","article-title":"Fetal fraction in maternal plasma cell-free DNA at 11\u201313 weeks\u2019 gestation: relation to maternal and fetal characteristics","volume":"41","author":"Ashoor","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.09.023_b0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/pd.5620","article-title":"Fetal fraction and noninvasive prenatal testing: What clinicians need to know","volume":"40","author":"Hui","year":"2020","journal-title":"Prenat Diagn"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.09.023_b0075","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/AOG.0000000000000363","article-title":"Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort","volume":"124","author":"Pergament","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.09.023_b0080","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/jhg.2016.25","article-title":"Fetal cell-free DNA fraction in maternal plasma is affected by fetal trisomy","volume":"61","author":"Suzumori","year":"2016","journal-title":"J Hum Genet"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.09.023_b0085","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/uog.15851","article-title":"Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result","volume":"47","author":"Revello","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.09.023_b0090","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/uog.20290","article-title":"First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure","volume":"53","author":"Galeva","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.09.023_b0095","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/pd.5693","article-title":"Most noninvasive prenatal screens failing due to inadequate fetal cell free DNA are negative for trisomy when repeated","volume":"40","author":"Lopes","year":"2020","journal-title":"Prenat Diagn"},{"issue":"8","key":"10.1016\/j.ejogrb.2023.09.023_b0100","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/pd.4608","article-title":"Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis","volume":"35","author":"Benn","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ejogrb.2023.09.023_b0105","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins- Obstetrics Committee on Genetics Society for Maternal-Fetal Medicine. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226. Obstet. Gynecol. 2020;136(4):e48-e69.","DOI":"10.1097\/AOG.0000000000004084"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.09.023_b0110","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/uog.18993","article-title":"Association between fetal fraction on cell-free DNA testing and first-trimester markers for pre-eclampsia","volume":"52","author":"Rolnik","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.09.023_b0115","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40291-018-0353-9","article-title":"Cell-free DNA (cfDNA) fetal fraction in early- and late-onset fetal growth restriction","volume":"22","author":"Morano","year":"2018","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.ejogrb.2023.09.023_b0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2019.04.002","article-title":"Low fetal fraction of cell-free DNA predicts placental dysfunction and hypertensive disease in pregnancy","volume":"16","author":"Gerson","year":"2019","journal-title":"Pregnancy Hypertens"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.09.023_b0125","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/pd.4779","article-title":"Adverse perinatal outcomes are more frequent in pregnancies with a low fetal fraction result on noninvasive prenatal testing","volume":"36","author":"Krishna","year":"2016","journal-title":"Prenat Diagn"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.09.023_b0130","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/pd.4119","article-title":"Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma","volume":"33","author":"Wang","year":"2013","journal-title":"Prenat Diagn"},{"issue":"8","key":"10.1016\/j.ejogrb.2023.09.023_b0135","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/pd.4625","article-title":"Factors affecting levels of circulating cell-free fetal DNA in maternal plasma and their implications for noninvasive prenatal testing","volume":"35","author":"Kinnings","year":"2015","journal-title":"Prenat Diagn"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.09.023_b0140","doi-asserted-by":"crossref","first-page":"413.e1","DOI":"10.1016\/j.ajog.2017.01.011","article-title":"Obesity and cell-free DNA \u201cno calls\u201d: is there an optimal gestational age at time of sampling?","volume":"216","author":"Livergood","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2023.09.023_b0145","doi-asserted-by":"crossref","unstructured":"Lee TJ, Rolnik DL, Menezes MA, et al. Cell-free fetal DNA testing in singleton IVF conceptions. Hum Reprod. 2018;33(4):572-578.","DOI":"10.1093\/humrep\/dey033"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.09.023_b0150","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000346806","article-title":"Maternal plasma cell-free fetal and maternal DNA at 11\u201313 Weeks\u2019 gestation: relation to fetal and maternal characteristics and pregnancy outcomes","volume":"33","author":"Poon","year":"2013","journal-title":"Fetal Diagn Ther"},{"issue":"11","key":"10.1016\/j.ejogrb.2023.09.023_b0155","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/oby.2012.138","article-title":"Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women","volume":"20","author":"Haghiac","year":"2012","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.09.023_b0160","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/uog.23763","article-title":"Influence of fibroids on cell-free DNA screening accuracy","volume":"59","author":"Scott","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.09.023_b0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1302736","article-title":"Characterization of uterine leiomyomas by whole-genome sequencing","volume":"369","author":"Mehine","year":"2013","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ejogrb.2023.09.023_b0170","doi-asserted-by":"crossref","unstructured":"Dharajiya NG, Grosu DS, Farkas DH, et al. Incidental detection of maternal neoplasia in noninvasive prenatal testing. Clin Chem. 2018;64(2):329-335.","DOI":"10.1373\/clinchem.2017.277517"},{"issue":"10","key":"10.1016\/j.ejogrb.2023.09.023_b0175","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/pd.6034","article-title":"Low fetal fraction in cell-free DNA testing is associated with adverse pregnancy outcome: Analysis of a subcohort of the TRIDENT-2 study","volume":"41","author":"Becking","year":"2021","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ejogrb.2023.09.023_b0180","doi-asserted-by":"crossref","unstructured":"Wright D, Syngelaki A, Akolekar R et al. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol. 2015;213(1):62.e1-62.e10.","DOI":"10.1016\/j.ajog.2015.02.018"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.09.023_b0185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40291-020-00468-5","article-title":"Circulating nucleic acids in maternal plasma and serum in pregnancy complications: are they really useful in clinical practice? A systematic review","volume":"24","author":"Carbone","year":"2020","journal-title":"Mol Diagn Ther"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.09.023_b0190","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40291-016-0245-9","article-title":"Cell-free fetal DNA for the prediction of pre-eclampsia at the first and second trimesters: A systematic review and meta-analysis","volume":"21","author":"Contro","year":"2017","journal-title":"Mol Diagn Ther"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.09.023_b0195","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/AOG.0000000000000874","article-title":"Cell-Free DNA analysis in maternal plasma in cases of fetal abnormalities detected on ultrasound examination","volume":"125","author":"Benachi","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"17","key":"10.1016\/j.ejogrb.2023.09.023_b0200","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA analysis for noninvasive examination of trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N Eng J Med"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.09.023_b0205","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000355655","article-title":"Prenatal detection of fetal triploidy from cell-free DNA testing in maternal blood","volume":"35","author":"Nicolaides","year":"2014","journal-title":"Fetal Diagn Ther"},{"issue":"11","key":"10.1016\/j.ejogrb.2023.09.023_b0210","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/pd.5152","article-title":"The association between anticoagulation therapy, maternal characteristics, and a failed cfDNA test due to a low fetal fraction","volume":"37","author":"Burns","year":"2017","journal-title":"Prenatal Diagn"},{"key":"10.1016\/j.ejogrb.2023.09.023_b0215","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/uog.17473","article-title":"Low-molecular-weight heparin associated with reduced fetal fraction and subsequent false-negative cell-free DNA test result for trisomy 21","volume":"51","author":"Ma","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.09.023_b0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/uog.14690","article-title":"Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies","volume":"45","author":"Bevilacqua","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.09.023_b0225","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/uog.15913","article-title":"Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy","volume":"47","author":"Sarno","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.09.023_b0230","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/pd.5609","article-title":"Cell-free DNA fetal fraction in twin gestations in single-nucleotide polymorphism-based noninvasive prenatal screening","volume":"40","author":"Hedriana","year":"2020","journal-title":"Prenat Diagn"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523007455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523007455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:01:44Z","timestamp":1759557704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211523007455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":46,"alternative-id":["S0301211523007455"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.09.023","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell free DNA screening for fetal aneuploidy in Ireland: An observational study of outcomes following insufficient fetal fraction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}